Loading…

EPITOP - Owned by ModeX Therapeutics, Inc. - (Class 042) | Sealvo

Home Search: EPITOPEPITOP #99037202

Updated Oct 16, 2026·26 searches this week

View on USPTO TSDR Find similar marks

EPI

USPTO Trademark Record

PENDING

EPITOP

SN 99037202·Reg 0·Filed Feb 11, 2025

Owner ModeX Therapeutics, Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

EPITOP (Serial No. 99037202), Registration No. 0, is a pending US trademark filed on Feb 11, 2025 by ModeX Therapeutics, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

Statement of Use due: October 21, 20265 days remaining

Mark Intelligence

EPITOP (Reg. #0) is a pending US trademark that was filed in 2025 and is currently under USPTO examination. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Feb 11, 2025

SERIAL

99037202

REG#

0

Filing Information

StatusPENDING

Filing DateFeb 11, 2025

Serial Number99037202

Registration No.0

Status DateMar 27, 2026

Published for OppositionAug 26, 2025

Mark TypeStandard characters

Filing Basis & Declarations

Standard Characters Claimed

Full Goods & Services

CLASSES

1

OFFICE

USPTO

COUNTRY

US

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

13 events

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 28, 2026

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Mar 27, 2026

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Mar 27, 2026

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Mar 27, 2026

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Oct 21, 2025

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Aug 26, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Aug 26, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Aug 20, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jul 24, 2025

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Jul 19, 2025

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 10, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Feb 11, 2025

NEW APPLICATION ENTERED

APPLICATION FILING RECEIPT MAILED

Feb 11, 2025

APPLICATION FILING RECEIPT MAILED

Other Marks by ModeX Therapeutics, Inc.

Additional USPTO filings from the same owner.

MODEX

99719206

ModeX Therapeutics, Inc.

MODEX

97788161

ModeX Therapeutics, Inc.

IMMUNOTOP

99037235

ModeX Therapeutics, Inc.

Other Marks by Jill Anderfuren

Additional USPTO filings handled by the same attorney of record.

C.

88495705

THE GOSPEL ON EVERY CAN

99441954

LOVE IN FAITH

99160678

ATMIX

76625331